{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T09:00:39Z","timestamp":1767085239945,"version":"3.37.3"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/02324-3","2015\/17539-5"],"award-info":[{"award-number":["2015\/02324-3","2015\/17539-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308674\/2015-4","306770\/2015-6"],"award-info":[{"award-number":["308674\/2015-4","306770\/2015-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pr\u00f3-Reitoria de Pesquisa, Universidade Estadual Paulista"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12933-016-0442-1","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T16:34:58Z","timestamp":1472834098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus"],"prefix":"10.1186","volume":"15","author":[{"given":"C. M.","family":"Rosa","sequence":"first","affiliation":[]},{"given":"R.","family":"Gimenes","sequence":"additional","affiliation":[]},{"given":"D. H. S.","family":"Campos","sequence":"additional","affiliation":[]},{"given":"G. N.","family":"Guirado","sequence":"additional","affiliation":[]},{"given":"C.","family":"Gimenes","sequence":"additional","affiliation":[]},{"given":"A. A. H.","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"A. C.","family":"Cicogna","sequence":"additional","affiliation":[]},{"given":"R. M.","family":"Queiroz","sequence":"additional","affiliation":[]},{"given":"I.","family":"Falc\u00e3o-Pires","sequence":"additional","affiliation":[]},{"given":"D.","family":"Miranda-Silva","sequence":"additional","affiliation":[]},{"given":"P.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"F. R.","family":"Laurindo","sequence":"additional","affiliation":[]},{"given":"D. C.","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"C. R.","family":"Correa","sequence":"additional","affiliation":[]},{"given":"M. P.","family":"Okoshi","sequence":"additional","affiliation":[]},{"given":"K.","family":"Okoshi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"442_CR1","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association. Circulation. 2016;133:e38\u2013360.","journal-title":"Circulation"},{"key":"442_CR2","first-page":"S13\u201322","volume":"39","author":"Association American Diabetes","year":"2016","unstructured":"Association American Diabetes. Classification and diagnosis of diabetes. Diabetes Care. 2016;39:S13\u201322.","journal-title":"Diabetes Care"},{"key":"442_CR3","doi-asserted-by":"crossref","first-page":"653789","DOI":"10.1155\/2013\/653789","volume":"2013","author":"AS Matheus","year":"2013","unstructured":"Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013;2013:653789.","journal-title":"Int J Hypertens"},{"key":"442_CR4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00395-011-0184-x","volume":"106","author":"I Falc\u00e3o-Pires","year":"2011","unstructured":"Falc\u00e3o-Pires I, Palladini G, Gon\u00e7alves N, van der Velden J, Moreira-Gon\u00e7alves D, Miranda-Silva D, et al. Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. Basic Res Cardiol. 2011;106:801\u201314.","journal-title":"Basic Res Cardiol"},{"key":"442_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1475-2840-12-152","volume":"12","author":"CM Rosa","year":"2013","unstructured":"Rosa CM, Xavier NP, Campos DHS, Fernandes AAH, Cezar MDM, Martinez PF, et al. Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats. Cardiovasc Diabetol. 2013;12:152.","journal-title":"Cardiovasc Diabetol"},{"key":"442_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2016.04.178","volume":"217","author":"N Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves N, Gomes-Ferreira C, Moura C, Roncon-Albuquerque R Jr, Leite-Moreira AF, Falc\u00e3o-Pires I. Worse cardiac remodeling in response to pressure overload in type 2 diabetes mellitus. Int J Cardiol. 2016;217:195\u2013204.","journal-title":"Int J Cardiol"},{"key":"442_CR7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/1056-8719(94)90092-2","volume":"32","author":"AJ Pijl","year":"1994","unstructured":"Pijl AJ, van der Wal AC, Mathy MJ, Kam KL, Hendriks MG, Pfaffendorf M, et al. Streptozotocin-induced diabetes mellitus in spontaneously hypertensive rats: a pathophysiological model for the combined effects of hypertension and diabetes. J Pharmacol Toxicol Methods. 1994;32:225\u201333.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"442_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3317\/jraas.2001.005","volume":"2","author":"W Wienen","year":"2001","unstructured":"Wienen W, Richard S, Champeroux P, Audeval-Gerard C. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats. J Renin Angiotensin Aldosterone Syst. 2001;2:31\u20136.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"442_CR9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1006\/jmcc.2001.1431","volume":"33","author":"LE Wold","year":"2001","unstructured":"Wold LE, Relling DP, Colligan PB, Scott GI, Hintz KK, Ren BH, et al. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes. J Mol Cell Cardiol. 2001;33:1719\u201326.","journal-title":"J Mol Cell Cardiol"},{"key":"442_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.carpath.2009.07.003","volume":"19","author":"MJ Black","year":"2010","unstructured":"Black MJ, D\u2019Amore A, Auden A, Stamp L, Osicka T, Panagiotopoulos S, et al. Chronic type 1 diabetes in spontaneously hypertensive rats leads to exacerbated cardiac fibrosis. Cardiovasc Pathol. 2010;19:361\u201370.","journal-title":"Cardiovasc Pathol"},{"key":"442_CR11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","volume":"90","author":"I Russo","year":"2016","unstructured":"Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2016;90:84\u201393.","journal-title":"J Mol Cell Cardiol"},{"issue":"Suppl 2","key":"442_CR12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2337\/dc08-s247","volume":"31","author":"TM Paravicini","year":"2008","unstructured":"Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care. 2008;31(Suppl 2):170\u201380.","journal-title":"Diabetes Care"},{"key":"442_CR13","doi-asserted-by":"crossref","first-page":"5698931","DOI":"10.1155\/2016\/5698931","volume":"2016","author":"SK Biswas","year":"2016","unstructured":"Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid Med Cell Longev. 2016;2016:5698931.","journal-title":"Oxid Med Cell Longev"},{"key":"442_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/ars.2013.5814","volume":"23","author":"S Altenhofer","year":"2014","unstructured":"Altenhofer S, Radermacher KA, Kleikers PWM, Wingler K, Schmidt HH. Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal. 2014;23:406\u201327.","journal-title":"Antioxid Redox Signal"},{"key":"442_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1475-2840-13-55","volume":"13","author":"ML Freidja","year":"2014","unstructured":"Freidja ML, Vessi\u00e8res E, Toutain B, Guihot AL, Custaud MA, Loufrani L, et al. AGEs breaking and antioxidant treatment improves endothelium-dependent dilation without effect on flow-mediated remodeling of resistance arteries in old Zucker diabetic rats. Cardiovasc Diabetol. 2014;13:55.","journal-title":"Cardiovasc Diabetol"},{"key":"442_CR16","doi-asserted-by":"crossref","first-page":"515042","DOI":"10.1155\/2015\/515042","volume":"2015","author":"AB Oyenihi","year":"2015","unstructured":"Oyenihi AB, Ayeleso AO, Mukwevho E, Masola B. Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int. 2015;2015:515042.","journal-title":"Biomed Res Int"},{"key":"442_CR17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jdi.12250","volume":"5","author":"Q Liu","year":"2014","unstructured":"Liu Q, Wang S, Cai L. Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J Diabetes Invest. 2014;5:623\u201334.","journal-title":"J Diabetes Invest"},{"key":"442_CR18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12933-015-0255-7","volume":"14","author":"JF Guimar\u00e3es","year":"2015","unstructured":"Guimar\u00e3es JF, Muzio BP, Rosa CM, Nascimento AF, Sugizaki MM, Fernandes AAH, et al. Rutin administration attenuates myocardial dysfunction in diabetic rats. Cardiovasc Diabetol. 2015;14:90.","journal-title":"Cardiovasc Diabetol"},{"key":"442_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(01)01516-3","volume":"433","author":"E Worm Van den","year":"2001","unstructured":"Van den Worm E, Beukelman CJ, Van den Berg AJ, Kroes BH, Labadie RP, Van Dijk H. Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol. 2001;433:225\u201330.","journal-title":"Eur J Pharmacol"},{"key":"442_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/HYPERTENSIONAHA.107.100214","volume":"51","author":"S Heum\u00fcller","year":"2008","unstructured":"Heum\u00fcller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schr\u00f6der K, et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension. 2008;51:211\u20137.","journal-title":"Hypertension"},{"key":"442_CR21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/HYPERTENSIONAHA.107.103200","volume":"51","author":"RM Touyz","year":"2008","unstructured":"Touyz RM. Apocynin, NADPH oxidase, and vascular cells: a complex matter. Hypertension. 2008;51:172\u20134.","journal-title":"Hypertension"},{"key":"442_CR22","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0735-1097(03)00471-6","volume":"41","author":"C Heymes","year":"2003","unstructured":"Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol. 2003;41:2164\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"442_CR23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1253\/circj.CJ-13-1187","volume":"78","author":"Y Teshima","year":"2014","unstructured":"Teshima Y, Takahashi N, Nishio S, Saito S, Kondo H, Fukui A, et al. Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase. Circ J. 2014;78:300\u20136.","journal-title":"Circ J"},{"key":"442_CR24","doi-asserted-by":"crossref","first-page":"25234","DOI":"10.3390\/ijms161025234","volume":"16","author":"Y Kayama","year":"2015","unstructured":"Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, et al. Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci. 2015;16:25234\u201363.","journal-title":"Int J Mol Sci"},{"key":"442_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2006.12.034","volume":"567","author":"H Ding","year":"2007","unstructured":"Ding H, Hashem M, Triggle C. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS. Eur J Pharmacol. 2007;567:121\u20138.","journal-title":"Eur J Pharmacol"},{"key":"442_CR26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.HYP.0000082814.62655.85","volume":"42","author":"JR Privratsky","year":"2003","unstructured":"Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension. 2003;42:206\u201312.","journal-title":"Hypertension"},{"key":"442_CR27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacc.2008.05.019","volume":"52","author":"G Zhou","year":"2008","unstructured":"Zhou G, Li X, Hein DW, Xiang X, Marshall JP, Prabhu SD, et al. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidade activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J Am Coll Cardiol. 2008;52:655\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"442_CR28","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2337\/db09-1800","volume":"59","author":"J Li","year":"2010","unstructured":"Li J, Zhu H, Shen E, Wan L, Arnold JM, Peng T. Deficiency of Rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress and reduces myocardial remodeling in type-I diabetic mice. Diabetes. 2010;59:2033\u201342.","journal-title":"Diabetes"},{"key":"442_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.06.070","author":"L Cairong","year":"2015","unstructured":"Cairong L, Shouyi G, Fei C. NADPH oxidase-dependent NLRP3 inflammasome activation and its important role in diabetic cardiomyopathy. J Am Coll Cardiol. 2015. doi: 10.1016\/j.jacc.2015.06.070 .","journal-title":"J Am Coll Cardiol"},{"key":"442_CR30","doi-asserted-by":"crossref","first-page":"C597","DOI":"10.1152\/ajpcell.00331.2011","volume":"302","author":"RM Maalouf","year":"2012","unstructured":"Maalouf RM, Eid AA, Gorin YC, Block K, Escobar GP, Bailey S, et al. Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes. Am J Physiol Cell Physiol. 2012;302:C597\u2013604.","journal-title":"Am J Physiol Cell Physiol"},{"key":"442_CR31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jdiacomp.2010.02.001","volume":"24","author":"M Olukman","year":"2010","unstructured":"Olukman M, Orhan CE, Celenk FG, Ulker S. Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions. J Diabetes Complications. 2010;24:415\u201323.","journal-title":"J Diabetes Complications"},{"key":"442_CR32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1463-1326.2011.01369.x","volume":"13","author":"ND Roe","year":"2011","unstructured":"Roe ND, Thomas DP, Ren J. Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction. Diabetes Obes Metab. 2011;13:465\u201373.","journal-title":"Diabetes Obes Metab"},{"key":"442_CR33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2010.04.030","volume":"638","author":"GS Dhaunsi","year":"2010","unstructured":"Dhaunsi GS, Yousif MH, Akhtar S, Chappell MC, Diz DI, Benter IF. Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities. Eur J Pharmacol. 2010;638:108\u201314.","journal-title":"Eur J Pharmacol"},{"key":"442_CR34","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.freeradbiomed.2010.03.010","volume":"48","author":"LRG Castor","year":"2010","unstructured":"Castor LRG, Locatelli KA, Ximenes VF. Pro-oxidant activity of apocynin radical. Free Radic Biol Med. 2010;48:1636\u201343.","journal-title":"Free Radic Biol Med"},{"key":"442_CR35","doi-asserted-by":"crossref","first-page":"7409196","DOI":"10.1155\/2016\/7409196","volume":"2016","author":"J Ku\u010dera","year":"2016","unstructured":"Ku\u010dera J, Bin\u00f3 L, \u0160tefkov\u00e1 K, Jaro\u0161 J, Va\u0161\u00ed\u010dek O, Ve\u010de\u0159a J, et al. Apocynin and diphenyleneiodonium induce oxidative stress and modulate PI3K\/Akt and MAPK\/Erk activity in mouse embryonic stem cells. Oxid Med Cell Longev. 2016;2016:7409196.","journal-title":"Oxid Med Cell Longev"},{"key":"442_CR36","doi-asserted-by":"crossref","first-page":"457848","DOI":"10.1155\/2015\/457848","volume":"2015","author":"C Gimenes","year":"2015","unstructured":"Gimenes C, Gimenes R, Rosa CM, Xavier NP, Campos DH, Fernandes AA, et al. Low intensity physical exercise attenuates cardiac remodeling and myocardial oxidative stress and dysfunction in diabetic rats. J Diabetes Res. 2015;2015:457848.","journal-title":"J Diabetes Res"},{"key":"442_CR37","first-page":"5","volume":"1","author":"BL Furman","year":"2015","unstructured":"Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol. 2015;1:5\u201347.","journal-title":"Curr Protoc Pharmacol"},{"key":"442_CR38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-2840-12-28","volume":"12","author":"J Lu","year":"2013","unstructured":"Lu J, Pontr\u00e9 B, Pickup S, Choong S, Li M, Xu H, et al. Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment. Cardiovasc Diabetol. 2013;12:28.","journal-title":"Cardiovasc Diabetol"},{"key":"442_CR39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1590\/S0100-879X2004000400019","volume":"37","author":"K Okoshi","year":"2004","unstructured":"Okoshi K, Fioretto JR, Okoshi MP, Cicogna AC, Aragon FF, Matsubara LS, et al. Food restriction induces in vivo ventricular dysfunction in spontaneously hypertensive rats without impairment of in vitro myocardial contractility. Braz J Med Biol Res. 2004;37:607\u201313.","journal-title":"Braz J Med Biol Res"},{"key":"442_CR40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1536\/jhj.45.647","volume":"45","author":"K Okoshi","year":"2004","unstructured":"Okoshi K, Ribeiro HB, Okoshi MP, Matsubara BB, Gon\u00e7alves G, Barros R, et al. Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy. Jpn Heart J. 2004;45:647\u201356.","journal-title":"Jpn Heart J"},{"key":"442_CR41","first-page":"374","volume":"16","author":"PF Martinez","year":"2010","unstructured":"Martinez PF, Okoshi K, Zornoff LAM, Carvalho RF, Oliveira Junior SA, Lima AR, et al. Chronic heart failure-induced skeletal muscle atrophy, necrosis, and myogenic regulatory factors changes. Med Sci Monit. 2010;16:374\u201383.","journal-title":"Med Sci Monit"},{"key":"442_CR42","doi-asserted-by":"crossref","first-page":"8695716","DOI":"10.1155\/2016\/8695716","volume":"2016","author":"MJ Gomes","year":"2016","unstructured":"Gomes MJ, Martinez PF, Campos DH, Pagan LU, Bonomo C, Lima AR, et al. Beneficial effects of physical exercise on functional capacity and skeletal muscle oxidative stress in rats with aortic stenosis-induced heart failure. Oxid Med Cell Longev. 2016;2016:8695716.","journal-title":"Oxid Med Cell Longev"},{"key":"442_CR43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0271-5317(01)00275-5","volume":"21","author":"AC Cicogna","year":"2001","unstructured":"Cicogna AC, Padovani CR, Okoshi K, Matsubara LS, Aragon FF, Okoshi MP. The influence of temporal food restriction on the performance of isolated cardiac muscle. Nutr Res. 2001;21:639\u201348.","journal-title":"Nutr Res"},{"key":"442_CR44","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1139\/y01-060","volume":"79","author":"MP Okoshi","year":"2001","unstructured":"Okoshi MP, Okoshi K, Dal Pai V, Dal Pai-Silva M, Matsubara LS, Cicogna AC. Mechanical, biochemical, and morphological changes in the heart from chronic food-restricted rats. Can J Physiol Pharmacol. 2001;79:754\u201360.","journal-title":"Can J Physiol Pharmacol"},{"key":"442_CR45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11373-005-7652-y","volume":"12","author":"MM Sugizaki","year":"2005","unstructured":"Sugizaki MM, Carvalho RF, Aragon FF, Padovani CR, Okoshi K, Okoshi MP, et al. Myocardial dysfunction induced by food restriction is related to morphological damage in normotensive middle-aged rats. J Biomed Sci. 2005;12:641\u20139.","journal-title":"J Biomed Sci"},{"key":"442_CR46","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1590\/S0100-879X1997000900013","volume":"30","author":"MP Okoshi","year":"1997","unstructured":"Okoshi MP, Matsubara LS, Franco M, Cicogna AC, Matsubara BB. Myocyte necrosis is the basis for fibrosis in renovascular hypertensive rats. Braz J Med Biol Res. 1997;30:1135\u201344.","journal-title":"Braz J Med Biol Res"},{"key":"442_CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000374053","volume":"36","author":"LU Pagan","year":"2015","unstructured":"Pagan LU, Damatto RL, Cezar MD, Lima AR, Bonomo C, Campos DH, et al. Long-term low intensity physical exercise attenuates heart failure development in aging spontaneously hypertensive rats. Cell Physiol Biochem. 2015;36:61\u201374.","journal-title":"Cell Physiol Biochem"},{"key":"442_CR48","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijcard.2016.04.101","volume":"215","author":"RL Damatto","year":"2016","unstructured":"Damatto RL, Lima ARR, Martinez PF, Cezar MDM, Okoshi K, Okoshi MP. Myocardial myostatin in spontaneously hypertensive rats with heart failure. Int J Cardiol. 2016;215:384\u20137.","journal-title":"Int J Cardiol"},{"key":"442_CR49","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1139\/y97-163","volume":"75","author":"LS Matsubara","year":"1997","unstructured":"Matsubara LS, Matsubara BB, Okoshi MP, Franco M, Cicogna AC. Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats. Can J Physiol Pharmacol. 1997;75:1328\u201334.","journal-title":"Can J Physiol Pharmacol"},{"key":"442_CR50","doi-asserted-by":"crossref","first-page":"H1274","DOI":"10.1152\/ajpheart.00174.2006","volume":"294","author":"X Yan","year":"2008","unstructured":"Yan X, Schuldt AJ, Price RL, Amende I, Liu FF, Okoshi K, et al. Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes. Am J Physiol Heart Circ Physiol. 2008;294:H1274\u201381.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"442_CR51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijcard.2012.03.063","volume":"167","author":"RL Damatto","year":"2013","unstructured":"Damatto RL, Martinez PF, Lima AR, Cezar MD, Campos DH, Oliveira Junior SA, et al. Heart failure-induced skeletal myopathy in spontaneously hypertensive rats. Int J Cardiol. 2013;167:698\u2013703.","journal-title":"Int J Cardiol"},{"key":"442_CR52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000369683","volume":"35","author":"PF Martinez","year":"2015","unstructured":"Martinez PF, Bonomo C, Guizoni DM, Oliveira Junior SA, Damatto RL, Cezar MDM, et al. Influence of N-acetylcysteine on oxidative stress in slow-twitch soleus muscle of heart failure rats. Cell Physiol Biochem. 2015;35:148\u201359.","journal-title":"Cell Physiol Biochem"},{"key":"442_CR53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","volume":"126","author":"L Heerebeek van","year":"2012","unstructured":"van Heerebeek L, Hamdani N, Falc\u00e3o-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, et al. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation. 2012;126:830\u20139.","journal-title":"Circulation"},{"key":"442_CR54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4239\/wjd.v6.i4.662","volume":"6","author":"PM Chen","year":"2015","unstructured":"Chen PM, Gregersen H, Zhao JB. Advanced glycation end-product expression is upregulated in the gastrointestinal tract of type 2 diabetic rats. World J Diabetes. 2015;6:662\u201372.","journal-title":"World J Diabetes"},{"key":"442_CR55","doi-asserted-by":"crossref","first-page":"C413","DOI":"10.1152\/ajpcell.00188.2006","volume":"292","author":"DC Fernandes","year":"2007","unstructured":"Fernandes DC, Wosniak JJ, Pescatore LA, Bertoline MA, Liberman M, Laurindo FR, et al. Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. Am J Phyiol Cell Physiol. 2007;292:C413\u201322.","journal-title":"Am J Phyiol Cell Physiol"},{"key":"442_CR56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0076-6879(08)01213-5","volume":"441","author":"FRM Laurindo","year":"2008","unstructured":"Laurindo FRM, Fernandes DC, Santos CXC. Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products. Methods Enzymol. 2008;441:237\u201360.","journal-title":"Methods Enzymol"},{"key":"442_CR57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.nutres.2006.09.012","volume":"26","author":"MP Okoshi","year":"2006","unstructured":"Okoshi MP, Okoshi K, Matsubara LS, Dal Pai-Silva M, Gut AL, Padovani CR, et al. Myocardial remodeling and dysfunction are induced by chronic food restriction in spontaneously hypertensive rats. Nutr Res. 2006;26:567\u201372.","journal-title":"Nutr Res"},{"key":"442_CR58","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1159\/000354526","volume":"32","author":"MD Cezar","year":"2013","unstructured":"Cezar MD, Damatto RL, Martinez PF, Lima ARR, Campos DH, Rosa CM, et al. Aldosterone blockade reduces mortality without changing cardiac remodeling in spontaneously hypertensive rats. Cell Physiol Biochem. 2013;32:1275\u201387.","journal-title":"Cell Physiol Biochem"},{"key":"442_CR59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/294284a0","volume":"294","author":"H Yamamoto","year":"1981","unstructured":"Yamamoto H, Uchigata Y, Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature. 1981;294:284\u20136.","journal-title":"Nature"},{"key":"442_CR60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF01919538","volume":"52","author":"FJ Bedoya","year":"1996","unstructured":"Bedoya FJ, Solano F, Lucas M. N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia. 1996;52:344\u20137.","journal-title":"Experientia"},{"key":"442_CR61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.phrs.2007.07.003","volume":"51","author":"P Sarkhail","year":"2007","unstructured":"Sarkhail P, Rahmaipour S, Fadyevatan S, Mohammadirad A, Dehghan G, Amin G. Antidiabetic effect of Phlomis anisodonta: effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res. 2007;51:261\u20136.","journal-title":"Pharmacol Res"},{"key":"442_CR62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40200-014-0084-3","volume":"13","author":"MR Parvizi","year":"2014","unstructured":"Parvizi MR, Parviz M, Tavangar SM, Soltani N, Kadkhodaee M, Seifi B, et al. Protective effect of magnesium on renal function in STZ-induced diabetic rats. Diabetes Metab Disord. 2014;13:84.","journal-title":"Diabetes Metab Disord"},{"key":"442_CR63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12933-015-0308-y","volume":"14","author":"C Malfitano","year":"2015","unstructured":"Malfitano C, de Souza Junior AL, Carbonaro M, Bolsoni-Lopes A, Figueroa D, de Souza LE, et al. Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2\u00a0weeks of tissue remodeling. Cardiovasc Diabetol. 2015;14:149.","journal-title":"Cardiovasc Diabetol"},{"key":"442_CR64","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0024-3205(03)00508-3","volume":"73","author":"MA Cotter","year":"2003","unstructured":"Cotter MA, Cameron NE. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci. 2003;73:1813\u201324.","journal-title":"Life Sci"},{"key":"442_CR65","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1210\/en.2007-1544","volume":"149","author":"XY Shi","year":"2008","unstructured":"Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology. 2008;149:1829\u201339.","journal-title":"Endocrinology"},{"key":"442_CR66","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/j.1523-1755.2005.00287.x","volume":"67","author":"K Asaba","year":"2005","unstructured":"Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, et al. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005;67:1890\u20138.","journal-title":"Kidney Int"},{"key":"442_CR67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/cvr\/cvn185","volume":"80","author":"T Schl\u00fcter","year":"2008","unstructured":"Schl\u00fcter T, Steinbach AC, Steffen A, Rettig R, Grisk O. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition. Cardiovasc Res. 2008;80:271\u20139.","journal-title":"Cardiovasc Res"},{"key":"442_CR68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.redox.2013.12.002","volume":"2","author":"A Rehman","year":"2014","unstructured":"Rehman A, Dugic E, Benham C, Lione I, Mackenzie LS. Selective inhibition of NADPH oxidase reverses the over contraction of diabetic rat aorta. Redox Biology. 2014;2:61\u20134.","journal-title":"Redox Biology"},{"key":"442_CR69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2013;18:149\u201366.","journal-title":"Heart Fail Rev"},{"key":"442_CR70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1475-2840-12-169","volume":"12","author":"QC Yong","year":"2013","unstructured":"Yong QC, Thomas CM, Seqqat R, Chandel N, Baker KM, Kumar R. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors. Cardiovasc Diabetol. 2013;12:169.","journal-title":"Cardiovasc Diabetol"},{"key":"442_CR71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2840-13-11","volume":"13","author":"MN Marangoni","year":"2014","unstructured":"Marangoni MN, Brady ST, Chowdhury SA, Piano MR. The co-occurrence of myocardial dysfunction and peripheral insensate neuropathy in a streptozotocin-induced rat model of diabetes. Cardiovasc Diabetol. 2014;13:11.","journal-title":"Cardiovasc Diabetol"},{"key":"442_CR72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","volume":"5","author":"D Fan","year":"2012","unstructured":"Fan D, Takawale A, Lee J, Kassiri Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair. 2012;5:15.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"442_CR73","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejcts.2006.07.006","volume":"30","author":"GL Brower","year":"2006","unstructured":"Brower GL, Gardner JD, Forman MF, Murray DB, Voloshenyuk T, Levick SP, et al. The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg. 2006;30:604\u201310.","journal-title":"Eur J Cardiothorac Surg"},{"key":"442_CR74","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00335.2010","volume":"299","author":"B L\u00f3pez","year":"2010","unstructured":"L\u00f3pez B, Gonz\u00e1lez A, Hermida N, Valencia F, de Teresa E, D\u00edez J. Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects. Am J Physiol Heart Circ Physiol. 2010;299:H1\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"442_CR75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12933-015-0173-8","volume":"14","author":"J Fuentes-Antr\u00e1s","year":"2015","unstructured":"Fuentes-Antr\u00e1s J, Picatoste B, Ram\u00edrez E, Egido J, Tu\u00f1\u00f3n J, Lorenzo O. Targeting metabolic disturbance in the diabetic heart. Cardiovasc Diabetol. 2015;14:17.","journal-title":"Cardiovasc Diabetol"},{"key":"442_CR76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1139\/Y10-063","volume":"88","author":"J Liu","year":"2010","unstructured":"Liu J, Zhou J, An W, Lin Y, Yang Y, Zang W. Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species. Can J Physiol Pharmacol. 2010;88:745\u201352.","journal-title":"Can J Physiol Pharmacol"},{"key":"442_CR77","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/aps.2012.164","volume":"34","author":"YQ Li","year":"2013","unstructured":"Li YQ, Li XB, Guo SJ, Chu SL, Gao PJ, Zhu DL, et al. Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice. Acta Pharmacol Sin. 2013;34:352\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"442_CR78","doi-asserted-by":"crossref","first-page":"e001598","DOI":"10.1161\/JAHA.114.001598","volume":"4","author":"Y Liu","year":"2015","unstructured":"Liu Y, Liu Y, Liu X, Chen J, Zhang K, Huang F, et al. Apocynin attenuates cardiac injury in type 4 cardiorenal syndrome via suppressing cardiac fibroblast growth factor-2 with oxidative stress inhibition. J Am Heart Assoc. 2015;4:e001598.","journal-title":"J Am Heart Assoc"},{"key":"442_CR79","doi-asserted-by":"crossref","first-page":"24699","DOI":"10.18632\/oncotarget.5084","volume":"6","author":"K Zhang","year":"2015","unstructured":"Zhang K, Liu Y, Liu X, Chen J, Cai Q, Wang J, et al. Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids. Oncotarget. 2015;6:24699\u2013708.","journal-title":"Oncotarget"},{"key":"442_CR80","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.taap.2005.07.011","volume":"212","author":"C Riganti","year":"2006","unstructured":"Riganti C, Costamagna C, Bosia A, Ghigo D. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress. Toxicol Appl Pharmacol. 2006;212:179\u201387.","journal-title":"Toxicol Appl Pharmacol"},{"key":"442_CR81","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","volume":"101","author":"Y Fujio","year":"2000","unstructured":"Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101:660\u20137.","journal-title":"Circulation"},{"key":"442_CR82","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.phymed.2015.06.011","volume":"22","author":"J Abrigo","year":"2015","unstructured":"Abrigo J, Morales MG, Simon F, Cabrera D, Di Capua G, Cabello-Verrugio C. Apocynin inhibits the upregulation of TGF-\u03b21 expression and ROS production induced by TGF-\u03b2 in skeletal muscle cells. Phytomedicine. 2015;22:885\u201393.","journal-title":"Phytomedicine"},{"key":"442_CR83","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.arcmed.2015.08.005","volume":"46","author":"YF Cagin","year":"2015","unstructured":"Cagin YF, Erdogan MA, Sahin N, Parlakpinar H, Atayan Y, Polat A, et al. Protective effects of apocynin on cisplatin-induced hepatotoxicity in rats. Arch Med Res. 2015;46:517\u201326.","journal-title":"Arch Med Res"},{"key":"442_CR84","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/03639045.2015.1052080","volume":"42","author":"YF Cagin","year":"2016","unstructured":"Cagin YF, Parlakpinar H, Polat A, Vardi N, Atayan Y, Erdogan MA, et al. The protective effects of apocynin on ionizing radiation-induced intestinal damage in rats. Drug Dev Ind Pharm. 2016;42:317\u201324.","journal-title":"Drug Dev Ind Pharm"},{"key":"442_CR85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12974-015-0325-5","volume":"12","author":"BY Choi","year":"2015","unstructured":"Choi BY, Kim JH, Kho AR, Kim IY, Lee SH, Lee BE, et al. Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice. J Neuroinflammation. 2015;12:104.","journal-title":"J Neuroinflammation"},{"key":"442_CR86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12013-007-0039-0","volume":"49","author":"S Vasdev","year":"2007","unstructured":"Vasdev S, Gill V, Singal P. Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications. Cell Biochem Biophys. 2007;49:48\u201363.","journal-title":"Cell Biochem Biophys"},{"key":"442_CR87","doi-asserted-by":"crossref","first-page":"726940","DOI":"10.1155\/2012\/726940","volume":"2012","author":"JL Miguel-Carrasco","year":"2012","unstructured":"Miguel-Carrasco JL, Baltan\u00e1s A, Cebri\u00e1n C, Moreno MU, L\u00f3pez B, Hermida N, et al. Blockade of TGF-\u03b2 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats. Oxid Med Cell Longev. 2012;2012:726940.","journal-title":"Oxid Med Cell Longev"},{"key":"442_CR88","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/CS20100529","volume":"121","author":"TI Lee","year":"2011","unstructured":"Lee TI, Kao YH, Chen YC, Pan NH, Lin YK, Chen YJ. Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes. Clin Sci. 2011;121:305\u201312.","journal-title":"Clin Sci"},{"key":"442_CR89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.taap.2007.12.013","volume":"228","author":"C Riganti","year":"2008","unstructured":"Riganti C, Costamagna C, Doublier S, Miraglia E, Polimeni M, Bosia A, et al. The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress. Toxicol Appl Pharmacol. 2008;228:277\u201385.","journal-title":"Toxicol Appl Pharmacol"},{"key":"442_CR90","doi-asserted-by":"crossref","first-page":"H1008","DOI":"10.1152\/ajpheart.00114.2008","volume":"295","author":"X Zhou","year":"2008","unstructured":"Zhou X, Bohlen GH, Miller SJ, Unthank JL. NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol Heart Circ Physiol. 2008;295:H1008\u201316.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"442_CR91","doi-asserted-by":"crossref","first-page":"L616","DOI":"10.1152\/ajplung.00064.2011","volume":"302","author":"S Wedgwood","year":"2012","unstructured":"Wedgwood S, Lakshminrusimha S, Farrow KN, Czech L, Gugino SF, Soares F, et al. Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol. 2012;302:L616\u201326.","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-016-0442-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T16:59:53Z","timestamp":1657213193000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-016-0442-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1186\/s12933-016-0442-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"type":"electronic","value":"1475-2840"}],"subject":[],"published":{"date-parts":[[2016,9,1]]},"article-number":"126"}}